No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.8940
- +0.1570+21.30%
Close Jul 3 13:00 ET
- 0.8901
- -0.0039-0.44%
Post 16:55 ET
8.79MMarket Cap-7P/E (TTM)
0.8950High0.7014Low4.52MVolume0.7400Open0.7370Pre Close3.72MTurnover45.95%Turnover RatioLossP/E (Static)9.83MShares60.160052wk High0.08P/B8.79MFloat Cap0.595052wk Low--Dividend TTM9.83MShs Float263679868.1600Historical High--Div YieldTTM26.27%Amplitude0.5950Historical Low0.8240Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Tonix Pharmaceuticals Secures $34M DoD Contract for Antiviral Program
Biopharmaceutical company Tonix Pharmaceuticals (NASDAQ:TNXP) awarded with a potential for up to $34M agreement over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense.
Express News | Tonix Pharmaceuticals Holding Corp - Program to Develop Orally Available Cd45 Antagonist
Express News | Tonix Pharmaceuticals Holding Corp - Contract to Develop Small Molecule Broad-Spectrum Antiviral Agents
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) today announced it has been awarded an Other Transaction Agreement (OTA) with a potential for up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense (DoD).
Express News | Tonix Pharmaceuticals Holding Shares Are Trading Lower. The Company Announced That It Entered Into an Agreement With the Defense Threat Reduction Agency for $34 Million to Develop Broad-spectrum Antiviral TNX-4200
Express News | Tonix Pharmaceuticals Entered Agreement With Defense Threat Reduction Agency For $34M To Develop Broad-Spectrum Antiviral, TNX-4200, Through Phase 1 Clinical Evaluation
Comments
$Tonix Pharmaceuticals(TNXP.US$ Sad R/S less than 30 days ago! Opened that morning at 2.50! Yes it’s moving a bit today! But shorts destroy companies! Im not talking retail shorts! Im talking institutional shorts! Lots of decent or could be decent companies are chased into the OTC which for many leads to way harder to raise capital to continue research! Grrrrr! sry. Just thinking outloud. Hehehe
2
2
$Tonix Pharmaceuticals(TNXP.US$ AH will be interesting.
1
1
$Tonix Pharmaceuticals(TNXP.US$ Tonix Pharmaceuticals Awarded up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
72840248 : shorts destroys companies in America, shorts is the problem of US stocks market and the authority are not ready to do anything about it.
TrytosaveabitOP 72840248: Yup you’re right! Lots of other countries have either put restrictions with severe penalties if those restrictions violated! And some have done away with short selling altogether! But in US even when they do break the minimal restrictions. The penalty is so meager that they just pay the fine and chalk it up to the cost of doing business! I mean if you make 10 million cheating, get caught and pay a 500K fine and go back to trading! Where is the actual deterrent? Cost of doing business! Hehehe